0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Activin A Market Research Report 2026
Published Date: 2026-02-27
|
Report Code: QYRE-Auto-35N5192
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
China Activin A Market Report Forecast 2021 2027
BUY CHAPTERS

Global Activin A Market Research Report 2026

Code: QYRE-Auto-35N5192
Report
2026-02-27
Pages:118
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Activin A Market Size

The global Activin A market was valued at US$ 23.35 million in 2025 and is anticipated to reach US$ 52.66 million by 2032, at a CAGR of 12.5% from 2026 to 2032.

Activin A Market

Activin A Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Activin A competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Activins, members of the TGF-beta superfamily, are disulfide-linked dimeric proteins originally purified from gonadal fluids as proteins that stimulated pituitary follicle stimulating hormone (FSH) release. Activin proteins have a wide range of biological activities, including mesoderm induction, neural cell differentiation, bone remodeling, hematopoiesis and roles in reproductive physiology. Activin isoforms and other members of the TGF-beta superfamily exert their biological effects by binding to heteromeric complexes of a type I and a type II serine-threonine kinase receptor, both of which are essential for signal transduction.In 2024, global Activin A production reached approximately 1115 mg, with an average global market price of around 18.4 USD/µg
With the rising incidence of cancers, fibrotic disorders, and reproductive / endocrine health issues such as PCOS or infertility, there is sharply increasing demand for novel diagnostic markers and therapeutic targets. Activin A’s central role in cellular signaling, immune modulation and tissue remodeling is drawing heightened attention from biopharma and academic researchers. In addition, the rise of regenerative medicine and stem cell therapies fuels demand for factors that can regulate stem cell fate and tissue repair, among which Activin A is prominent. Biotechnology innovations—improvements in recombinant expression systems, purification and stability enhancements, as well as delivery system optimization—are reducing production costs and risks of quality, enabling broader application from only high-end research to diagnostics and therapeutic products. Government and regulatory policies in many countries supporting biomarkers and precision medicine, along with public funding, further release opportunities for market growth.
Despite many opportunities, the Activin A market faces notable risks. First, the biological mechanisms of Activin A are complex and highly context-dependent: its effects may be beneficial or harmful depending on disease state, dose, timing and tissue, which complicates therapeutic designs of neutralizing agents or antagonists and raises safety/efficacy uncertainties. Second, the R&D to clinical clinical trial path is long and expensive; proving efficacy and safety in specific indications in animal models and humans requires substantial investment in time and money, which is a barrier especially for smaller firms. Third, regulatory approval pathways vary widely across geographies: quality, safety, delivery format, combination therapies, and biomarker validation are addressed differently, and changes or delays in regulation can lengthen time to market. Also, competition is intensifying among established biotech / pharmaceutical companies, academic labs, and startups; differentiation, intellectual property protection, and effective commercialization strategies become critical.
Downstream demand is shifting from purely research reagents toward combined diagnostics + therapeutics. Research institutions continue to purchase Activin A proteins, antibodies, and assay kits, but diagnostic laboratories and clinical settings are increasingly adopting Activin A as a biomarker for early disease detection (cancer, fibrosis, inflammatory diseases). Biopharma firms are progressing therapeutic development targeting Activin A (neutralizing antibodies, receptor antagonists) in indication areas such as antifibrosis, tumor suppression, and enhancing tissue regeneration. Precision medicine / personalized therapeutic strategies are favoring monitoring of Activin A levels or activity for patient stratification. Geographically, emerging regions (Asia, Latin America, Middle East) are increasing their investment in health research infrastructure, so demand growth in Activin A-related products is accelerating there relative to mature markets
Upstream raw inputs include recombinant Activin A expression systems (e.g. bacterial, yeast, mammalian cell lines), culture media and components, purification media and buffers, stability enhancers, QC reagents and analytical assays, antibodies or antagonists for neutralization, etc. A single-line capacity refers to a full production line from expression → purification → quality control → formulation/stability (liquid / freeze-dried) → packaging & distribution. Within such a line, expression system choice and correct folding / modification are key bottlenecks; purification and removal of endotoxins or unintended impurities are demanding; QC including bioactivity assays and safety validations determine whether outputs meet clinical-grade or just research-grade standards. Research reagent / ELISA-level Activin A products have shorter lead times and lower investment for single-line deployment; but therapeutic products—especially neutralizing antibodies, receptor antagonists, or those delivered via novel delivery systems—require much larger capital, facilities, skilled personnel, and longer development & validation times.
This report delivers a comprehensive overview of the global Activin A market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Activin A. The Activin A market size, estimates, and forecasts are provided in terms of sales volume (mg) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Activin A market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Activin A manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Activin A Market Report

Report Metric Details
Report Name Activin A Market
Accounted market size in 2025 US$ 23.35 million
Forecasted market size in 2032 US$ 52.66 million
CAGR 12.5%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Activin-A Human
  • Activin-A Mouse (Rat)
by Application
  • Commercial Research
  • Academic Research
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Merck Millipore, Thermo Fisher Scientific, Bio-Techne, StemRD, Prospec, Proteintech Group, Ajinomoto, Enzo Life Sciences, IBL, STEMCELL, Sino Biological, PeproTech, ReproCELL
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Activin A manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Activin A sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Activin A Market growing?

Ans: The Activin A Market witnessing a CAGR of 12.5% during the forecast period 2026-2032.

What is the Activin A Market size in 2032?

Ans: The Activin A Market size in 2032 will be US$ 52.66 million.

Who are the main players in the Activin A Market report?

Ans: The main players in the Activin A Market are Merck Millipore, Thermo Fisher Scientific, Bio-Techne, StemRD, Prospec, Proteintech Group, Ajinomoto, Enzo Life Sciences, IBL, STEMCELL, Sino Biological, PeproTech, ReproCELL

What are the Application segmentation covered in the Activin A Market report?

Ans: The Applications covered in the Activin A Market report are Commercial Research, Academic Research

What are the Type segmentation covered in the Activin A Market report?

Ans: The Types covered in the Activin A Market report are Activin-A Human, Activin-A Mouse (Rat)

1 Activin A Market Overview
1.1 Product Definition
1.2 Activin A by Type
1.2.1 Global Activin A Market Value by Type: 2025 vs 2032
1.2.2 Activin-A Human
1.2.3 Activin-A Mouse (Rat)
1.3 Activin A by Application
1.3.1 Global Activin A Market Value by Application: 2025 vs 2032
1.3.2 Commercial Research
1.3.3 Academic Research
1.4 Global Activin A Market Size Estimates and Forecasts
1.4.1 Global Activin A Revenue 2021–2032
1.4.2 Global Activin A Sales 2021–2032
1.4.3 Global Activin A Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Activin A Market Competition by Manufacturers
2.1 Global Activin A Sales Market Share by Manufacturers (2021–2026)
2.2 Global Activin A Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Activin A Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Activin A, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Activin A, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Activin A, Product Types and Applications
2.7 Global Key Manufacturers of Activin A, Date of Entry into the Industry
2.8 Global Activin A Market Competitive Situation and Trends
2.8.1 Global Activin A Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Activin A Players Market Share by Revenue
2.8.3 Global Activin A Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Activin A Market Scenario by Region
3.1 Global Activin A Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Activin A Sales by Region: 2021–2032
3.2.1 Global Activin A Sales by Region: 2021–2026
3.2.2 Global Activin A Sales by Region: 2027–2032
3.3 Global Activin A Revenue by Region: 2021–2032
3.3.1 Global Activin A Revenue by Region: 2021–2026
3.3.2 Global Activin A Revenue by Region: 2027–2032
3.4 North America Activin A Market Facts & Figures by Country
3.4.1 North America Activin A Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Activin A Sales by Country (2021–2032)
3.4.3 North America Activin A Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Activin A Market Facts & Figures by Country
3.5.1 Europe Activin A Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Activin A Sales by Country (2021–2032)
3.5.3 Europe Activin A Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Activin A Market Facts & Figures by Region
3.6.1 Asia Pacific Activin A Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Activin A Sales by Region (2021–2032)
3.6.3 Asia Pacific Activin A Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Activin A Market Facts & Figures by Country
3.7.1 Latin America Activin A Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Activin A Sales by Country (2021–2032)
3.7.3 Latin America Activin A Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Activin A Market Facts & Figures by Country
3.8.1 Middle East and Africa Activin A Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Activin A Sales by Country (2021–2032)
3.8.3 Middle East and Africa Activin A Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Activin A Sales by Type (2021–2032)
4.1.1 Global Activin A Sales by Type (2021–2026)
4.1.2 Global Activin A Sales by Type (2027–2032)
4.1.3 Global Activin A Sales Market Share by Type (2021–2032)
4.2 Global Activin A Revenue by Type (2021–2032)
4.2.1 Global Activin A Revenue by Type (2021–2026)
4.2.2 Global Activin A Revenue by Type (2027–2032)
4.2.3 Global Activin A Revenue Market Share by Type (2021–2032)
4.3 Global Activin A Price by Type (2021–2032)
5 Segment by Application
5.1 Global Activin A Sales by Application (2021–2032)
5.1.1 Global Activin A Sales by Application (2021–2026)
5.1.2 Global Activin A Sales by Application (2027–2032)
5.1.3 Global Activin A Sales Market Share by Application (2021–2032)
5.2 Global Activin A Revenue by Application (2021–2032)
5.2.1 Global Activin A Revenue by Application (2021–2026)
5.2.2 Global Activin A Revenue by Application (2027–2032)
5.2.3 Global Activin A Revenue Market Share by Application (2021–2032)
5.3 Global Activin A Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Merck Millipore
6.1.1 Merck Millipore Company Information
6.1.2 Merck Millipore Description and Business Overview
6.1.3 Merck Millipore Activin A Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Merck Millipore Activin A Product Portfolio
6.1.5 Merck Millipore Recent Developments/Updates
6.2 Thermo Fisher Scientific
6.2.1 Thermo Fisher Scientific Company Information
6.2.2 Thermo Fisher Scientific Description and Business Overview
6.2.3 Thermo Fisher Scientific Activin A Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Thermo Fisher Scientific Activin A Product Portfolio
6.2.5 Thermo Fisher Scientific Recent Developments/Updates
6.3 Bio-Techne
6.3.1 Bio-Techne Company Information
6.3.2 Bio-Techne Description and Business Overview
6.3.3 Bio-Techne Activin A Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Bio-Techne Activin A Product Portfolio
6.3.5 Bio-Techne Recent Developments/Updates
6.4 StemRD
6.4.1 StemRD Company Information
6.4.2 StemRD Description and Business Overview
6.4.3 StemRD Activin A Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 StemRD Activin A Product Portfolio
6.4.5 StemRD Recent Developments/Updates
6.5 Prospec
6.5.1 Prospec Company Information
6.5.2 Prospec Description and Business Overview
6.5.3 Prospec Activin A Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Prospec Activin A Product Portfolio
6.5.5 Prospec Recent Developments/Updates
6.6 Proteintech Group
6.6.1 Proteintech Group Company Information
6.6.2 Proteintech Group Description and Business Overview
6.6.3 Proteintech Group Activin A Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Proteintech Group Activin A Product Portfolio
6.6.5 Proteintech Group Recent Developments/Updates
6.7 Ajinomoto
6.7.1 Ajinomoto Company Information
6.7.2 Ajinomoto Description and Business Overview
6.7.3 Ajinomoto Activin A Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Ajinomoto Activin A Product Portfolio
6.7.5 Ajinomoto Recent Developments/Updates
6.8 Enzo Life Sciences
6.8.1 Enzo Life Sciences Company Information
6.8.2 Enzo Life Sciences Description and Business Overview
6.8.3 Enzo Life Sciences Activin A Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Enzo Life Sciences Activin A Product Portfolio
6.8.5 Enzo Life Sciences Recent Developments/Updates
6.9 IBL
6.9.1 IBL Company Information
6.9.2 IBL Description and Business Overview
6.9.3 IBL Activin A Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 IBL Activin A Product Portfolio
6.9.5 IBL Recent Developments/Updates
6.10 STEMCELL
6.10.1 STEMCELL Company Information
6.10.2 STEMCELL Description and Business Overview
6.10.3 STEMCELL Activin A Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 STEMCELL Activin A Product Portfolio
6.10.5 STEMCELL Recent Developments/Updates
6.11 Sino Biological
6.11.1 Sino Biological Company Information
6.11.2 Sino Biological Description and Business Overview
6.11.3 Sino Biological Activin A Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Sino Biological Activin A Product Portfolio
6.11.5 Sino Biological Recent Developments/Updates
6.12 PeproTech
6.12.1 PeproTech Company Information
6.12.2 PeproTech Description and Business Overview
6.12.3 PeproTech Activin A Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 PeproTech Activin A Product Portfolio
6.12.5 PeproTech Recent Developments/Updates
6.13 ReproCELL
6.13.1 ReproCELL Company Information
6.13.2 ReproCELL Description and Business Overview
6.13.3 ReproCELL Activin A Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 ReproCELL Activin A Product Portfolio
6.13.5 ReproCELL Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Activin A Industry Chain Analysis
7.2 Activin A Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Activin A Production Mode & Process Analysis
7.4 Activin A Sales and Marketing
7.4.1 Activin A Sales Channels
7.4.2 Activin A Distributors
7.5 Activin A Customer Analysis
8 Activin A Market Dynamics
8.1 Activin A Industry Trends
8.2 Activin A Market Drivers
8.3 Activin A Market Challenges
8.4 Activin A Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Activin A Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Activin A Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Activin A Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Activin A Sales (mg) of Key Manufacturers (2021–2026)
 Table 5. Global Activin A Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Activin A Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Activin A Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Activin A Average Price (US$/mg) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Activin A, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Activin A, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Activin A, Product Types and Applications
 Table 12. Global Key Manufacturers of Activin A, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Activin A Companies by Tier (Tier 1, Tier 2, Tier 3), based on Activin A Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Activin A Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Activin A Sales by Region (mg), 2021–2026
 Table 18. Global Activin A Sales Market Share by Region (2021–2026)
 Table 19. Global Activin A Sales by Region (mg), 2027–2032
 Table 20. Global Activin A Sales Market Share by Region (2027–2032)
 Table 21. Global Activin A Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Activin A Revenue Market Share by Region (2021–2026)
 Table 23. Global Activin A Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Activin A Revenue Market Share by Region (2027–2032)
 Table 25. North America Activin A Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Activin A Sales by Country (mg), 2021–2026
 Table 27. North America Activin A Sales by Country (mg), 2027–2032
 Table 28. North America Activin A Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Activin A Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Activin A Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Activin A Sales by Country (mg), 2021–2026
 Table 32. Europe Activin A Sales by Country (mg), 2027–2032
 Table 33. Europe Activin A Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Activin A Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Activin A Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Activin A Sales by Region (mg), 2021–2026
 Table 37. Asia Pacific Activin A Sales by Region (mg), 2027–2032
 Table 38. Asia Pacific Activin A Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Activin A Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Activin A Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Activin A Sales by Country (mg), 2021–2026
 Table 42. Latin America Activin A Sales by Country (mg), 2027–2032
 Table 43. Latin America Activin A Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Activin A Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Activin A Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Activin A Sales by Country (mg), 2021–2026
 Table 47. Middle East and Africa Activin A Sales by Country (mg), 2027–2032
 Table 48. Middle East and Africa Activin A Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Activin A Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Activin A Sales (mg) by Type (2021–2026)
 Table 51. Global Activin A Sales (mg) by Type (2027–2032)
 Table 52. Global Activin A Sales Market Share by Type (2021–2026)
 Table 53. Global Activin A Sales Market Share by Type (2027–2032)
 Table 54. Global Activin A Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Activin A Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Activin A Revenue Market Share by Type (2021–2026)
 Table 57. Global Activin A Revenue Market Share by Type (2027–2032)
 Table 58. Global Activin A Price (US$/mg) by Type (2021–2026)
 Table 59. Global Activin A Price (US$/mg) by Type (2027–2032)
 Table 60. Global Activin A Sales (mg) by Application (2021–2026)
 Table 61. Global Activin A Sales (mg) by Application (2027–2032)
 Table 62. Global Activin A Sales Market Share by Application (2021–2026)
 Table 63. Global Activin A Sales Market Share by Application (2027–2032)
 Table 64. Global Activin A Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Activin A Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Activin A Revenue Market Share by Application (2021–2026)
 Table 67. Global Activin A Revenue Market Share by Application (2027–2032)
 Table 68. Global Activin A Price (US$/mg) by Application (2021–2026)
 Table 69. Global Activin A Price (US$/mg) by Application (2027–2032)
 Table 70. Merck Millipore Company Information
 Table 71. Merck Millipore Description and Business Overview
 Table 72. Merck Millipore Activin A Sales (mg), Revenue (US$ Million), Price (US$/mg), and Gross Margin (2021–2026)
 Table 73. Merck Millipore Activin A Product
 Table 74. Merck Millipore Recent Developments/Updates
 Table 75. Thermo Fisher Scientific Company Information
 Table 76. Thermo Fisher Scientific Description and Business Overview
 Table 77. Thermo Fisher Scientific Activin A Sales (mg), Revenue (US$ Million), Price (US$/mg), and Gross Margin (2021–2026)
 Table 78. Thermo Fisher Scientific Activin A Product
 Table 79. Thermo Fisher Scientific Recent Developments/Updates
 Table 80. Bio-Techne Company Information
 Table 81. Bio-Techne Description and Business Overview
 Table 82. Bio-Techne Activin A Sales (mg), Revenue (US$ Million), Price (US$/mg), and Gross Margin (2021–2026)
 Table 83. Bio-Techne Activin A Product
 Table 84. Bio-Techne Recent Developments/Updates
 Table 85. StemRD Company Information
 Table 86. StemRD Description and Business Overview
 Table 87. StemRD Activin A Sales (mg), Revenue (US$ Million), Price (US$/mg), and Gross Margin (2021–2026)
 Table 88. StemRD Activin A Product
 Table 89. StemRD Recent Developments/Updates
 Table 90. Prospec Company Information
 Table 91. Prospec Description and Business Overview
 Table 92. Prospec Activin A Sales (mg), Revenue (US$ Million), Price (US$/mg), and Gross Margin (2021–2026)
 Table 93. Prospec Activin A Product
 Table 94. Prospec Recent Developments/Updates
 Table 95. Proteintech Group Company Information
 Table 96. Proteintech Group Description and Business Overview
 Table 97. Proteintech Group Activin A Sales (mg), Revenue (US$ Million), Price (US$/mg), and Gross Margin (2021–2026)
 Table 98. Proteintech Group Activin A Product
 Table 99. Proteintech Group Recent Developments/Updates
 Table 100. Ajinomoto Company Information
 Table 101. Ajinomoto Description and Business Overview
 Table 102. Ajinomoto Activin A Sales (mg), Revenue (US$ Million), Price (US$/mg), and Gross Margin (2021–2026)
 Table 103. Ajinomoto Activin A Product
 Table 104. Ajinomoto Recent Developments/Updates
 Table 105. Enzo Life Sciences Company Information
 Table 106. Enzo Life Sciences Description and Business Overview
 Table 107. Enzo Life Sciences Activin A Sales (mg), Revenue (US$ Million), Price (US$/mg), and Gross Margin (2021–2026)
 Table 108. Enzo Life Sciences Activin A Product
 Table 109. Enzo Life Sciences Recent Developments/Updates
 Table 110. IBL Company Information
 Table 111. IBL Description and Business Overview
 Table 112. IBL Activin A Sales (mg), Revenue (US$ Million), Price (US$/mg), and Gross Margin (2021–2026)
 Table 113. IBL Activin A Product
 Table 114. IBL Recent Developments/Updates
 Table 115. STEMCELL Company Information
 Table 116. STEMCELL Description and Business Overview
 Table 117. STEMCELL Activin A Sales (mg), Revenue (US$ Million), Price (US$/mg), and Gross Margin (2021–2026)
 Table 118. STEMCELL Activin A Product
 Table 119. STEMCELL Recent Developments/Updates
 Table 120. Sino Biological Company Information
 Table 121. Sino Biological Description and Business Overview
 Table 122. Sino Biological Activin A Sales (mg), Revenue (US$ Million), Price (US$/mg), and Gross Margin (2021–2026)
 Table 123. Sino Biological Activin A Product
 Table 124. Sino Biological Recent Developments/Updates
 Table 125. PeproTech Company Information
 Table 126. PeproTech Description and Business Overview
 Table 127. PeproTech Activin A Sales (mg), Revenue (US$ Million), Price (US$/mg), and Gross Margin (2021–2026)
 Table 128. PeproTech Activin A Product
 Table 129. PeproTech Recent Developments/Updates
 Table 130. ReproCELL Company Information
 Table 131. ReproCELL Description and Business Overview
 Table 132. ReproCELL Activin A Sales (mg), Revenue (US$ Million), Price (US$/mg), and Gross Margin (2021–2026)
 Table 133. ReproCELL Activin A Product
 Table 134. ReproCELL Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Activin A Distributors List
 Table 138. Activin A Customers List
 Table 139. Activin A Market Trends
 Table 140. Activin A Market Drivers
 Table 141. Activin A Market Challenges
 Table 142. Activin A Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Activin A
 Figure 2. Global Activin A Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Activin A Market Share by Type: 2025 & 2032
 Figure 4. Activin-A Human Product Picture
 Figure 5. Activin-A Mouse (Rat) Product Picture
 Figure 6. Global Activin A Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Activin A Market Share by Application: 2025 & 2032
 Figure 8. Commercial Research
 Figure 9. Academic Research
 Figure 10. Global Activin A Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 11. Global Activin A Market Size (US$ Million), 2021–2032
 Figure 12. Global Activin A Sales (mg), 2021–2032
 Figure 13. Global Activin A Average Price (US$/mg), 2021–2032
 Figure 14. Activin A Report Years Considered
 Figure 15. Activin A Sales Share by Manufacturers in 2025
 Figure 16. Global Activin A Revenue Share by Manufacturers in 2025
 Figure 17. Top 5 and Top 10 Global Activin A Players: Market Share by Revenue in Activin A in 2025
 Figure 18. Activin A Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 19. Global Activin A Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 20. North America Activin A Sales Market Share by Country (2021–2032)
 Figure 21. North America Activin A Revenue Market Share by Country (2021–2032)
 Figure 22. U.S. Activin A Revenue Growth Rate (US$ Million), 2021–2032
 Figure 23. Canada Activin A Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Europe Activin A Sales Market Share by Country (2021–2032)
 Figure 25. Europe Activin A Revenue Market Share by Country (2021–2032)
 Figure 26. Germany Activin A Revenue Growth Rate (US$ Million), 2021–2032
 Figure 27. France Activin A Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. U.K. Activin A Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. Italy Activin A Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Russia Activin A Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Asia Pacific Activin A Sales Market Share by Region (2021–2032)
 Figure 32. Asia Pacific Activin A Revenue Market Share by Region (2021–2032)
 Figure 33. China Activin A Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Japan Activin A Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. South Korea Activin A Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. India Activin A Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. Australia Activin A Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Taiwan Activin A Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Indonesia Activin A Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Thailand Activin A Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Malaysia Activin A Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Philippines Activin A Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Latin America Activin A Sales Market Share by Country (2021–2032)
 Figure 44. Latin America Activin A Revenue Market Share by Country (2021–2032)
 Figure 45. Mexico Activin A Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Brazil Activin A Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Argentina Activin A Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Middle East and Africa Activin A Sales Market Share by Country (2021–2032)
 Figure 49. Middle East and Africa Activin A Revenue Market Share by Country (2021–2032)
 Figure 50. Turkey Activin A Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Saudi Arabia Activin A Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. UAE Activin A Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Global Sales Market Share of Activin A by Type (2021–2032)
 Figure 54. Global Revenue Market Share of Activin A by Type (2021–2032)
 Figure 55. Global Activin A Price (US$/mg) by Type (2021–2032)
 Figure 56. Global Sales Market Share of Activin A by Application (2021–2032)
 Figure 57. Global Revenue Market Share of Activin A by Application (2021–2032)
 Figure 58. Global Activin A Price (US$/mg) by Application (2021–2032)
 Figure 59. Activin A Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI